Skip to content

Finnish Imaging of Shoulder Trauma

Finnish Imaging of Shoulder Trauma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05800184
Acronym
FIMAGE-T
Enrollment
40
Registered
2023-04-05
Start date
2023-04-05
Completion date
2025-12-31
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glenoid Labrum Tear, Rotator Cuff Tears, Shoulder Injuries, Shoulder Pain

Keywords

Shoulder, Injury, Rotator Cuff, Magnetic resonance Imaging

Brief summary

The FIMAGE-Trauma study is an extension of the FIMAGE study and aims to answer the question if rotator cuff tears found on shoulder imaging after a shoulder injury are caused by the index trauma or are rather incidental findings. Eligible participants of the FIMAGE study will be invited to a follow up visit in the case of a shoulder injury or a sudden onset of significant shoulder symptoms (within a 2-year time frame). These findings will then be compared to the baseline data collected in the FIMAGE study (including the comparison of pre-injury and post-injury MRI:s)

Interventions

None listed

Sponsors

Helsinki University Central Hospital
CollaboratorOTHER
University of Helsinki
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Ambulatory * Participated in the FIMAGE * Baseline MRI from FIMAGE study available

Exclusion criteria

* Contraindications to MRI * Previous shoulder joint replacement * Previous rotator cuff surgery

Design outcomes

Primary

MeasureTime frameDescription
Rotator Cuff Integrity on Shoulder Magnetic Resonance Imaging (MRI)At baselineBilateral shoulder MRI comparing the integrity of the rotator cuff tendons on pre-injury and post-injury MRI scans. Each of the four rotator cuff tendons (supraspinatus, infraspinatus, teres minor, subscapularis) will be assessed and graded for structural changes (normal, tendinopathy, partial thickness tear, full thickness tear). The dimensions of full thickness tears will be measured and recorded (size in millimeters).
Shoulder Pain and Disability Index (SPADI)At baselinePatient reported outcome measure. The Shoulder Pain and Disability Index (SPADI) was developed to measure current shoulder pain and disability in an outpatient setting. The SPADI contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability. A SPADI total score ranging from 0 (best) to 100 (worst) is produced by averaging the two subscale scores.
Constant -Murley ScoreAt baselineThe Constant-Murley Score was designed to assess the functional state of a shoulder and contains both physician- completed and patient-reported portions. The four domains include pain (15 possible points), activities of daily living (20 possible points), mobility (40 possible points), and strength (25 possible points). Scores range from 0 points (most disability) to 100 points (least disability).

Secondary

MeasureTime frameDescription
Subjective Shoulder Value (SSV)At baselineThe SSV score is defined as the subjective evaluation by the patient of shoulder function, expressed as a percentage of a normal shoulder. This score ranges from 0 to 100%.
Pain NRSAt baselineThe numeric rating scale (NRS) is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning no pain and 10 meaning the worst pain imaginable.

Other

MeasureTime frameDescription
Clinical Shoulder ExaminationAt baselineThe clinical examination will include orthopaedic shoulder tests used to assess rotator cuff integrity (internal rotation lag sign, lift off, press belly, hornblower sign, bear hug test, drop arm sign, external rotation lag sign).

Countries

Finland

Contacts

Primary ContactThomas Ibounig, MD
thomas.ibounig@helsinki.fi+358504286223
Backup ContactSaara Raatikainen
saara.raatikainen@hus.fi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026